Alireza is a Senior Scientific Director and Senior Research Fellow with the BetaLogics Venture, a division of Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The mission of BetaLogics is to develop a cell therapy product to cure insulin-requiring diabetes. In his position, Alireza leads a team engaged in discovery and product development of a therapy comprised of a cellular component encapsulated in an immune isolation device to treat Type I diabetes. He is the inventor on over 50 issued patents and applications and over 20 peer reviewed publications.
This interview is part of the American Institute for Medical and Biological Engineering's website initiative for STEM education: Navigate the Circuit (navigate.aimbe.org)